open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:
Get Citation

The results of postoperative radiotherapy in patients with renal cell carcinoma in third stage of clinical advancement based on data of Greatpoland Cancer Centre

M. Matecka-Nowak, E. Adamiak, G. Stryczyńska
DOI: 10.1016/S1428-2267(97)70135-2
·
Rep Pract Oncol Radiother 1997;2(2):53.

open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:

Abstract

The role of complementary radiotherapy in patients with stage III renal cell carcinoma after radical nephrectomy still remains a matter of discussion. In connection with lack of alternative solutions the treatment is still conducted in many centres. In Greatpoland Cancer Centre in period 1985–1991 complementary radiotherapy was carried out in 169 patients with infiltration of adipose capsule and/or renal stalk or metastases in closest lymph nodes confirmed during operation.

The patients were irradiated from two opposite fields including a bed of the removed kidney and regional lymph nodes. Total dose amounted 50 Gy (25 fractions), 2 Gy daily, five times a week.

Early complications after radiotherapy like lack of appetite, diarrhoea and moderate leucopenia, disappearing after pharmacologhical treatment, were observed in 20% of patients and did not cause interruption in treatment. No late complications were observed.

5-year survival without recurrence was achieved in 47% of thease patients. In the whole group only four local recurrences were found. The reasons of treatment failure were distant metastases. We proved that teleradiotherapy turned out to be efficient method protecting against local recurrence of disease but did not influence significantly 5-year survival rate.

Abstract

The role of complementary radiotherapy in patients with stage III renal cell carcinoma after radical nephrectomy still remains a matter of discussion. In connection with lack of alternative solutions the treatment is still conducted in many centres. In Greatpoland Cancer Centre in period 1985–1991 complementary radiotherapy was carried out in 169 patients with infiltration of adipose capsule and/or renal stalk or metastases in closest lymph nodes confirmed during operation.

The patients were irradiated from two opposite fields including a bed of the removed kidney and regional lymph nodes. Total dose amounted 50 Gy (25 fractions), 2 Gy daily, five times a week.

Early complications after radiotherapy like lack of appetite, diarrhoea and moderate leucopenia, disappearing after pharmacologhical treatment, were observed in 20% of patients and did not cause interruption in treatment. No late complications were observed.

5-year survival without recurrence was achieved in 47% of thease patients. In the whole group only four local recurrences were found. The reasons of treatment failure were distant metastases. We proved that teleradiotherapy turned out to be efficient method protecting against local recurrence of disease but did not influence significantly 5-year survival rate.

Get Citation
About this article
Title

The results of postoperative radiotherapy in patients with renal cell carcinoma in third stage of clinical advancement based on data of Greatpoland Cancer Centre

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 2, No 2 (1997)

Pages

53

Published online

1997-01-01

DOI

10.1016/S1428-2267(97)70135-2

Bibliographic record

Rep Pract Oncol Radiother 1997;2(2):53.

Authors

M. Matecka-Nowak
E. Adamiak
G. Stryczyńska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl